Cargando…
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Favipiravir has been developed as an anti-influenza drug and licensed as an anti-influenza drug in Japan. Additionally, favipiravir is being stockpiled for 2 million people as a countermeasure for novel influenza strains. This drug functions as a chain terminator at the site of incorporation of the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102570/ https://www.ncbi.nlm.nih.gov/pubmed/32097670 http://dx.doi.org/10.1016/j.pharmthera.2020.107512 |